The UCSF Brain Tumor Center has research and clinical trial programs focused on brain tumors, including potential use of leronlimab, an immunotherapy drug. The Lu Lab and Okada Lab at UCSF are actively researching immunotherapy strategies for brain tumors, including CAR-T cell therapy and other approaches. UCSF Clinical Trials lists ongoing clinical trials related to brain tumors, which may include studies exploring leronlimab or similar immunotherapies.

This is where Michael Tilson Thomas is treated.